アジェンダ
8:00 AM — 9:00 AM
9:00 AM — 9:10 AM
9:30 AM — 11:00 AM
Session 1: Biosimilar Medicines Regulatory Framework Review11:00 AM — 11:30 AM
11:30 AM — 1:00 PM
Session 2: Physician’s Challenges – Treatment Pathways1:00 PM — 2:00 PM
2:00 PM — 3:30 PM
Session 3: Sustainability of the Biosimilar Medicines Sector3:30 PM — 4:00 PM
4:00 PM — 5:30 PM
Session 4: International Regulator Updates5:30 PM — 6:30 PM
Networking Reception9:30 AM — 10:00 AM
FDA’s Biosimilars Access Plan10:00 AM — 12:00 PM
Session 5: Patient Education12:00 PM — 1:30 PM
1:30 PM — 3:00 PM
Session 6: Lessons Learned